We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Optimer Pockets $68 Million From Astellas for Rights to Antibiotic in Europe
Optimer Pockets $68 Million From Astellas for Rights to Antibiotic in Europe
February 8, 2011
San Diego-based Optimer Pharmaceuticals has found a partner to help market its most important drug candidate outside the U.S. Xconomy
